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Abstract 
We set out to review the recent incidence of
extravasation and compartment syndrome in
children with meningococcal disease admitted
to our Paediatric Intensive Care Unit (PICU)
who had been resuscitated with intraosseous
(IO) needles. Over a 12-month period, 18 chil-
dren were admitted to PICU with meningococ-
cal sepsis. Four of these children were resusci-
tated with IO needles and 2 developed serious
complications as a result of extravasation and
compartment  syndrome.  Clinical  practice
guidelines  for  children  with  severe  sepsis
advocate  aggressive  early  fluid  resuscitation
therapy. We have identified extravasation and
lower  limb  injury  as  a  potential  issue  of
increasing  concern  with  appropriate  aggres-
sive  IO  fluid  resuscitation  in  severe  septic
shock in children. Powered IO access systems
such as the EZ-IO system offer advantages in
terms of placement speed, accuracy and bone
entry  site  profile  at  minimal  extra  financial
cost.
Introduction
Meningococcal disease (MCD) continues to
be the most common infective cause of death
in children in the United Kingdom. In cases of
severe  septic  shock,  children  frequently
require  large  volumes  of  fluid  resuscitation
and when faced with difficult vascular access,
the  intraosseous  (IO)  route  offers  a  prompt
and  effective  route  through  which  to  infuse
resuscitation fluids and drugs. Extravasation
is a well recognised complication of IO access
leading to limb-threatening events.
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Over a 12-month period, 18 children with
meningococcal  sepsis  were  admitted  to  our
Paediatric Intensive Care Unit (PICU). Four of
these children had IO needles inserted in their
referring  hospitals  and  2  developed  serious
complications as a result of these. The local
ethics committee has approved this paper for
publication.
Case #1
A 20-month old girl presented to her local
Emergency Department with severe MCD. She
had an IO needle sited in her right tibia during
initial resuscitation and she received in total
120ml/kg of crystalloid boluses and 30 mL/kg of
colloid boluses prior to transfer to the PICU.
Her  right  lower  leg  became  increasingly
swollen and tense; 15 hours after admission a
diagnosis of compartment syndrome was made
and fasciotomy of all lower limb compartments
was carried out.
Six  days  after  admission  she  underwent
debridement of her right lower leg which was
repeated on day 8. When she was taken to the-
atre for skin grafting on day 11, the tibia was
noted to be necrotic (Figure 1) and a bone scan
confirmed avascular necrosis and shortening
of  the  tibia.  Two  months  later  radiological
assessment of the affected leg revealed wide-
spread skeletal changes with periosteal new
bone formation along the tibial shaft but with
no residual osteomyelitis.
Case #2
A  5-month  old  girl  presented  to  her  local
Emergency Department with severe MCD. She
required bilateral tibial IO line insertion dur-
ing her initial resuscitation and received 120
mL/kg of resuscitation fluid (0.9% saline and
colloids) through these lines along with bolus
doses  of  50%  glucose  solution,  calcium  glu-
conate  10%  and  sodium  bicarbonate  8.4%.
Extravasation  was  noted  in  the  Emergency
Department and within two hours of presenta-
tion both lower limbs were swollen and tense.
Immediate  bilateral  fasciotomy  of  all  lower
limb compartments was carried out but unfor-
tunately  perfusion  of  her  legs  continued  to
deteriorate and she eventually required bilat-
eral below knee amputation two weeks later.
Discussion
The technique of IO needle insertion was
initially  described  in  the  1920s  and  1930s
when  investigators  conducting  bone  marrow
transplant research noted that the marrow cav-
ity of a long bone was a promising site for vas-
cular access. During World War II, IO access,
particularly  of  the  sternum,  was  reportedly
widespread but after the 1940s, during an era
in which there was little pre-hospital care, the
technique fell out of routine use. Interest was
rekindled in the 1980s and since then the tech-
nique  has  become  commonplace  during  the
care of critically ill children, particularly during
their initial resuscitation.
Potential complications of IO access include
failure of the technique due to the device or
the  operator,  extravasation  injury,  compart-
ment syndrome with or without limb amputa-
tion,
2 bone infections, although a meta-analy-
sis review of 4,270 cases of IO use found only
27  cases  of  osteomyelitis  (0.63%),  fat
embolism, skin necrosis, growth plate damage
and  fractures.  Risk  of  injury  to  the  growth
plates has been shown to be small by following
serial  tibial  measurements  in  children  aged
one year and over after having an IO needle
placed with no clinically significant difference
between control and infusion leg lengths.
Over the last decade there has been a signif-
icant improvement in mortality rates of chil-
dren with MCD. The reasons for this are mul-
tifactorial, but one of the major contributory
factors has been recognition of the benefit of
aggressive  early  fluid  resuscitation  and
inotrope therapy. Clinical practice guidelines
for  children  with  severe  sepsis  produced  by
Carcillo et al.
3 advocate the administration of
‘up to and over 60 mL/kg’ of resuscitation fluid
within 15 minutes of arrival in the Emergency
Department.  A  specific  early  management
algorithm for MCD which has been extensive-
ly  distributed  and  utilized  throughout
Emergency Departments and Paediatric units
in  the  UK  has  been  recently  updated.
4 This
algorithm  also  recommends  aggressive  fluid
resuscitation  therapy  with  initial  20  mL/kg
boluses of colloid or crystalloid solutions each
given over 5-10 minutes.
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There is concern that the rate of complica-
tions of IO access, particularly extravasation
injury  and  compartment  syndrome,  may
increase in children with severe septic shock
as  patients  appropriately  receive  larger  vol-
umes  of  resuscitation  fluid  through  these
lines. In a recent study of pediatric IO lines,
Fiorito documented complications in 7 of 58 IO
placements (12%), all limited to local edema or
infiltration; it should be noted, however, that
only 11% of patients in this study had a diagno-
sis of sepsis and as such the majority of the
children included in this study will not have
received large volumes of fluid intraosseously.
Manual insertion of IO needles results in an
irregular entry site into bone (Figure 2A) mak-
ing extravasation more likely. In contrast, pow-
ered or assisted IO access systems can provide
more rapid access to the vascular compartment
and result in a very regular entry site, mini-
mizing the risks of extravasation (Figure 2B).
The EZ-IO system by Vidacare consists of a
small  hand-held  battery-powered  drill  device
and bevelled, hollow drill-tipped needles which
may be quickly and easily placed in children
and adults. We have used this system with suc-
cess in the PICU and during the retrieval of
critically ill children. Depth of needle insertion
is  accurately  controlled  and  IO  infusion  can
usually be commenced within 60 seconds of
starting  the  procedure.  The  reusable  EZ-IO
drill costs around £190, whilst the EZ-IO nee-
dles are of a similar price to standard hand-
held IO needles. In a recent prospective multi-
center study of 250 adult patients in the pre-
hospital  setting,  the  EZ-IO  system  was
deployed with a 97% success rate, with a mean
insertion time of ten seconds and with a mean
pain score in alert patients of 3.8 (on a 1-10
visual analog scale).
5
Other  assisted  IO  access  systems  include
the Bone Injection Gun (BIG) and the FAST1
system. The BIG by WaisMed comes in a range
of  sizes  including  a  pediatric  model;  it  is
spring loaded and automatically fires a needle
directly into the bone. Anecdotal reports have
linked the deployment of this device with tibial
fractures.
6 The  FAST1  system  by  the  Pyng
Medical  Corporation  is  a  specific  sternal  IO
device for adults, which has been most widely
used in defens medicine.
Conclusions
There is little published data available on
changes  in  the  pattern  of  morbidity  due  to
MCD. Given the improvements in overall mor-
tality we have seen over recent years, there
will inevitably be a greater focus on the quality
of life of survivors, with survival being at min-
imum cost rather than at any cost. We have
identified extravasation and lower limb injury
as a potential issue of increasing concern with
appropriate aggressive IO fluid resuscitation
in severe septic shock in children. Powered IO
access systems such as the EZ-IO system offer
advantages in terms of placement speed, accu-
racy  and  bone  entry  site  profile  at  minimal
extra financial cost. Systems such as the EZ-IO
warrant formal evaluation to assess their safe-
ty and complication profiles.
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Case Report
Figure 2A and B. Entry sites in bone sam-
ples following IO access.
Figure 1. Tibial osteomyelitis.
(A) Manual IO insertion (B) EZ-IO insertion